These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 22949875)

  • 1. The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.
    Kumar H; Lim HW; More SV; Kim BW; Koppula S; Kim IS; Choi DK
    Int J Mol Sci; 2012; 13(8):10478-10504. PubMed ID: 22949875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in Parkinson's disease.
    Jenner P
    Ann Neurol; 2003; 53 Suppl 3():S26-36; discussion S36-8. PubMed ID: 12666096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox imbalance in Parkinson's disease.
    Chinta SJ; Andersen JK
    Biochim Biophys Acta; 2008 Nov; 1780(11):1362-7. PubMed ID: 18358848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death of dopamine neurons in aging and Parkinson's disease.
    Naoi M; Maruyama W
    Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and the pathogenesis of Parkinson's disease.
    Jenner P; Olanow CW
    Neurology; 1996 Dec; 47(6 Suppl 3):S161-70. PubMed ID: 8959985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
    Bobela W; Aebischer P; Schneider BL
    Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
    Giordano S; Darley-Usmar V; Zhang J
    Redox Biol; 2014; 2():82-90. PubMed ID: 24494187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
    Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
    Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
    Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
    Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
    Dubinina EE; Pustygina AV
    Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
    Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
    J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein, lipids and Parkinson's disease.
    Ruipérez V; Darios F; Davletov B
    Prog Lipid Res; 2010 Oct; 49(4):420-8. PubMed ID: 20580911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.